Recombinant Human SAA1 (N-6His)(Cat. No.:C633) novoprotein
$150.00
In stock
SKU
C633
10μg: $150
50μg: $440
500μg: $1540
1mg: $2400
Description
Recombinant Human Serum Amyloid A1 Protein is produced by our E.coli expression system and the target gene encoding Arg19-Tyr122 is expressed with a 6His tag at the N-terminus.
Product Details
| Item | Details |
| Known As | Serum Amyloid A-1 Protein; SAA; SAA1 |
| Mol Mass | 13.2 KDa |
| APMol Mass | 14 KDa, reducing conditions |
| Formulation Description | Lyophilized from a 0.2 μm filtered solution of 20mM Tris-HCl, 150mM NaCl, 1mM EDTA, pH 8.0. |
| Endotoxin | < 1 EU/µg as determined by LAL test. |
| Reconstitution | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
| Storage | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below. |
Background
Serum Amyloid A1 Protein (SAA1) is an acute phase apolipoprotein reactant that is produced predominantly by hepatocytes and is under the regulation of inflammatory cytokines. SAA is produced mainly in the liver and circulates in low levels in the blood. SAA may play a role in the immune system and facilitate the repair of injured tissues, it also acts as an antibacterial agent, and signals the migration of germ-fighting cells to sites of infection. SAA also functions as an apolipoprotein of the HDL complex. The SAA cleavage product designated amyloid protein A is deposited systemically as amyloid in vital organs such as the liver, spleen, and kidneys in chronic inflammatory diseases patients. These deposits are extremely insoluble and resistant to proteolysis; they disrupt tissue structure and compromise performance.
title: TNFSF10 drives hyperactive immune responses via NLRP3 inflammasome and endoplasmic reticulum stress in autoimmune and inflammatory diseases
authors: Huilin Zhang, Yaoyao Chen, Yingmei Li, Chang Chen, Bingjie Wang, Fanxiang Yin, Yunling Zhu, Jiani Li, Jin Li, Ping Tang, Juanxia Zhou, Shaohua Yan, Bo Qin, Qingxuan Xin, Shuya Wang, Qiankun Yang, Baohong Yue, Yong Jiang, Rongqun Guo
date: 2026/01/16
journal: Journal of Advanced Research
title: Arecoline induces epithelial‐mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression
authors: Hui Ren, Guoqin He, Zhiyuan Lu, Qianting He, Shuai Li, Zhexun Huang, Zheng Chen, Congyuan Cao, Anxun Wang
date: 2021
journal: CANCER SCIENCE
title: A fully validated liquid chromatography-mass spectrometry method for the quantification of the soluble receptor of advanced glycation end-products (sRAGE) in serum using immunopurification in a 96-well plate format
authors: Frank Klont, Simon D. Pouwels, Jos Hermans, Nico C. van de Merbel, Péter Horvatovich, Nick H.T. ten Hacken, Rainer Bischoff
date: 2018
journal: TALANTA
MDSD
Reviews
Write Your Own Review